Correction

A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

N Engl J Med 1996; 334:1143April 25, 1996

Article

A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis (Original Article, N Engl J Med 1995:332;1457 - 1463) . On page 1461, the numbers in the legend for Figure 1 were calculated incorrectly. The corrected legend appears below.

Among the patients with normal serum alanine aminotransferase concentrations at six months, histologic improvement was observed in 78.6 percent of the patients in group 1 (22 of 28), 68.0 percent of those in group 2 (17 of 25), and 55.0 percent of those in group 3 (11 of 20). Among the patients with elevated serum alanine aminotransferase concentrations at six months, histologic improvement was observed in 60.7 percent of the patients in group 1 (17 of 28), 34.2 percent of those in group 2 (13 of 38), and 29.7 percent of those in group 3 (11 of 37). Among the patients with normal serum alanine aminotransferase concentrations at 18 months, histologic improvement was observed in 83.9 percent of the patients in group 1 (26 of 31), 72.2 percent of those in group 2 (13 of 18), and 57.9 percent of those in group 3 (11 of 19). Among the patients with elevated serum alanine aminotransferase concentrations at 18 months, histologic improvement was observed in 52.0 percent of those in group 1 (13 of 25), 37.8 percent of those in group 2 (17 of 45), and 28.9 percent of those in group 3 (11 of 38).